Cardinal Health raises FY25 EPS guidance to $8.15-$8.20; sets FY26 preliminary EPS $9.10-$9.30

CARDINAL HEALTH INC

Raising FY25 non-GAAP diluted EPS to $8.15-$8.20 (from $8.05-$8.15); 9% growth at midpoint.
Preliminary FY26 non-GAAP diluted EPS $9.10-$9.30 (+13% growth); adjusted FCF $2.75B-$3.25B.
Long-term FY26-FY28: 12-14% EPS CAGR; at least $10B total adjusted FCF; buybacks raised to $750M/year.
Launched The Specialty Alliance (GI Alliance, Urology Alliance); expanding Biopharma Solutions; new distribution center planned.
GMPD long-term target: $50M+ profit growth/year after FY26; FY25 GMPD profit narrowed to ~$130M.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.